HK1180230A1 - Use of a fermented soy extract for manufacture of a prebiotic composition - Google Patents

Use of a fermented soy extract for manufacture of a prebiotic composition

Info

Publication number
HK1180230A1
HK1180230A1 HK13107557.5A HK13107557A HK1180230A1 HK 1180230 A1 HK1180230 A1 HK 1180230A1 HK 13107557 A HK13107557 A HK 13107557A HK 1180230 A1 HK1180230 A1 HK 1180230A1
Authority
HK
Hong Kong
Prior art keywords
manufacture
prebiotic composition
fermented soy
soy extract
extract
Prior art date
Application number
HK13107557.5A
Other languages
English (en)
Chinese (zh)
Inventor
庄明恒
游丞德
路孔明
Original Assignee
中天生物科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中天生物科技股份有限公司 filed Critical 中天生物科技股份有限公司
Publication of HK1180230A1 publication Critical patent/HK1180230A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK13107557.5A 2010-07-20 2013-06-27 Use of a fermented soy extract for manufacture of a prebiotic composition HK1180230A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36588710P 2010-07-20 2010-07-20
PCT/CN2011/001188 WO2012009961A1 (en) 2010-07-20 2011-07-20 Use of a fermented soy extract for manufacture of a prebiotic composition

Publications (1)

Publication Number Publication Date
HK1180230A1 true HK1180230A1 (en) 2013-10-18

Family

ID=45496476

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13107557.5A HK1180230A1 (en) 2010-07-20 2013-06-27 Use of a fermented soy extract for manufacture of a prebiotic composition

Country Status (12)

Country Link
US (1) US9259450B2 (ja)
EP (1) EP2595641B1 (ja)
JP (1) JP6005041B2 (ja)
KR (1) KR101849424B1 (ja)
CN (1) CN103079583B (ja)
BR (1) BR112013001369B1 (ja)
CA (1) CA2805319C (ja)
HK (1) HK1180230A1 (ja)
MY (1) MY170190A (ja)
SG (2) SG10201505609YA (ja)
TW (1) TWI552685B (ja)
WO (1) WO2012009961A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6333509B2 (ja) * 2012-06-22 2018-05-30 雪印メグミルク株式会社 還元された桂皮酸類縁化合物含有画分の製造方法
JP6605319B2 (ja) * 2015-12-17 2019-11-13 株式会社ダイワ 乳酸菌含有加工食品の製造方法
EP3436067A4 (en) * 2016-03-30 2019-11-13 Microbio Co., Ltd. ANTICANCER POLY THERAPY BASED ON MODULATORS OF IMMUNE CONTROL POINTS AND FERMENTATION PRODUCTS GENERATED BY A SYMBIOTIC MICROBIOTIC

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60134386D1 (de) * 2001-03-21 2008-07-24 Microbio Co Ltd Verfahren zur Hemmung von Krebswachstum mit einem fermentierten Soja- Extrakt
US20020182274A1 (en) * 2001-03-21 2002-12-05 Kung-Ming Lu Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
US20040219237A1 (en) * 2002-06-25 2004-11-04 Kung-Ming Lu Process of using fermented Glycine max (L.) extract for enhancing natural killer cell activity and inhibitory activities to GABA and glutamate receptor binding
EP1512407A1 (en) * 2003-09-02 2005-03-09 Microbio Company, Ltd. Use of fermented glycine max (L.) extract in inhibiting 15-lipoxygenase
CA2470090A1 (fr) * 2004-06-18 2005-12-18 Bio-K Plus International Inc. Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques
CA2690058A1 (en) 2006-06-09 2007-12-13 9205-5961 Quebec Inc. Fermented probiotic beverages and uses thereof
KR100926170B1 (ko) * 2007-10-05 2009-11-10 정재수 엽산이 혼입된 대두 발효 고분자물질 및 이를 포함하는조성물
CN101692876A (zh) * 2009-09-18 2010-04-14 姜波 仔猪饲料

Also Published As

Publication number Publication date
CA2805319A1 (en) 2012-01-26
US20120058104A1 (en) 2012-03-08
EP2595641B1 (en) 2018-03-14
US9259450B2 (en) 2016-02-16
KR20130136434A (ko) 2013-12-12
CA2805319C (en) 2020-06-30
KR101849424B1 (ko) 2018-05-31
SG187554A1 (en) 2013-03-28
BR112013001369A2 (pt) 2020-10-06
CN103079583B (zh) 2015-03-25
CN103079583A (zh) 2013-05-01
BR112013001369B1 (pt) 2022-03-22
TWI552685B (zh) 2016-10-11
WO2012009961A1 (en) 2012-01-26
JP2013535439A (ja) 2013-09-12
TW201218965A (en) 2012-05-16
EP2595641A4 (en) 2014-01-01
EP2595641A1 (en) 2013-05-29
MY170190A (en) 2019-07-09
JP6005041B2 (ja) 2016-10-12
SG10201505609YA (en) 2015-09-29

Similar Documents

Publication Publication Date Title
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
IL222199A0 (en) Process for preparation of dopo-derived compounds and compositions thereof
HK1178465A1 (en) Composition for improving condition of skin
EP2560484A4 (en) PHARMACEUTICAL COMPOSITION FROM NANOPARTICLES
EP2668281A4 (en) COMPOSITIONS AND METHODS OF SUCCINATE MANUFACTURE
GB2493441B (en) Leg prosthesis
GB201016832D0 (en) Garment technology for application of therapeutic pressure
GB201011991D0 (en) Improvements relating to valves
EP2563768A4 (en) MANUFACTURE OF FEBUXOSTAT
ZA201303617B (en) Method of sintering a composition
HK1180230A1 (en) Use of a fermented soy extract for manufacture of a prebiotic composition
PT2785769E (pt) Composição endurecedora de epóxi e composições derivadas
PL2407155T3 (pl) Formulacje inekalcytolu
HRP20220523T8 (hr) Prirodni ljekoviti spoj
HK1178025A1 (en) Extract of teas
PL3097920T3 (pl) Kompozycja medyczna zawierająca ekstrakt stauntonia hexaphylla
LT2654770T (lt) Tenekteplazės farmacinės kompozicijos
PL2513060T3 (pl) Krystaliczna postać α karbabenzopirydu
GB0922023D0 (en) Preparation of n-monofluoroalkyl compounds
HK1183207A1 (en) Extract of teas
HK1179120A1 (en) Extract of teas
EP2702991A4 (en) COMPOSITION OF ENTACOPONE
EP2459540A4 (en) PREPARATION OF FIPAMEZOLE
AU2010903172A0 (en) Use of a nutraceutical composition
PL392894A1 (pl) Preparat o właściwościach prebiotycznych